rxstat › Shortages › Docusate
Docusate shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Docusate products are in shortage in Canada (1 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Apr 15, 2016
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageSELAX SYR 20MG/5ML USP
20MG · SYRUP · ODAN LABORATORIES LTD
DIN 00695033 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
ResolvedTARO-DOCUSATE
100MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 00716731 · ended Nov 18, 2025 · Other (Please describe in comments)
DiscontinuedDOCUSATE SODIUM
100MG · CAPSULE · PRO DOC LIMITEE
DIN 02326086
ResolvedDOCUSATE SODIUM
100MG · CAPSULE · PRO DOC LIMITEE
DIN 02326086 · ended Jun 30, 2025 · Disruption of the manufacture of the drug.
ResolvedDOCUSATE SODIUM
100MG · CAPSULE · SANIS HEALTH INC
DIN 02426838 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
DiscontinuedSANDOZ DOCUSATE SODIUM
100MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02247385
ResolvedSANDOZ DOCUSATE SODIUM
100MG · CAPSULE · SANDOZ CANADA INCORPORATED
DIN 02247385 · ended May 1, 2024 · Disruption of the manufacture of the drug.
ResolvedSOFLAX CAPSULES 100MG
100MG · CAPSULE · PHARMASCIENCE INC
DIN 01994344 · ended Apr 17, 2024 · Disruption of the manufacture of the drug.
ResolvedSOFLAX CAPSULES 100MG
100MG · CAPSULE · PHARMASCIENCE INC
DIN 01994344 · ended Apr 2, 2024 · Disruption of the manufacture of the drug.
ResolvedRATIO-DOCUSATE SODIUM
20MG · SYRUP · TEVA CANADA LIMITED
DIN 00870226 · ended Dec 10, 2023 · Disruption of the manufacture of the drug.
ResolvedTARO-DOCUSATE
100MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 00716731 · ended Nov 28, 2023 · Delay in shipping of the drug.
ResolvedTARO-DOCUSATE
100MG · CAPSULE · TARO PHARMACEUTICALS INC
DIN 00716731 · ended Nov 28, 2023 · Delay in shipping of the drug.
Showing 12 of 50 reports. All reports are on file with Health Canada.
What's happening
Docusate is currently affected by an active shortage report filed with Health Canada by ODAN LABORATORIES LTD.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Docusate is classified under “DRUGS FOR CONSTIPATION” (ATC A06AA).
Recent changes
Common questions
When will Docusate be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Docusate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.